Research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
The latest OUS research blog is written by Petter Strømme and Gro Anita Gauslå from the Department of Clinical Neurosciences for Children at the Woman and Children's Division at OUS. The blog is entitled "Grave metabolic diseases may be treated" and discusses how chronic and incurable diseases that affect children's nervous system now may be treated with increasingly good results.
Åsmund Eikenes from Harald Stenmark's lab at the department of Molecular Cell Biology has written a column in the careers section of the May 6th edition of Nature (journal impact factor 42.4). The article is entitled "Visual maps bring research to life".
In the short essay, Åsmund argues that scientists could benefit from actively using techniques from storytelling to improve their scientific work.
About 40 teams from Oslo University Hospital participated in this year's Holmenkollstafetten, Norway's largest sport event in number of participants (about 51 000). With 15 members on each team, each running between 390 and 2800 meters, this relay race acts as an inspiring annual event, triggering activities at the work places before and after the race, contributing to the improvement of the general public health at the institution. It is not the running of the particular stretch on race day that is important in this respect, it is the training leading up to the event that can make a difference. The Holmenkollstafetten has become an important social happening for many departments at the hospital.
Three scientists received awards for their outstanding work at a ceremony taking place at Oslo University Hospital April 24th. The major prize - the "Excellent Researcher Award" - went to professor Anne-Lise Børresen-Dale. Jan Terje Andersen and Jon Arne Dahl both received the "Early Career Award". The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities. This is the third year such prizes have been distributed in order to honour excellent scientific achievements.
In a recent OUS research blog article (in Norwegian) Anja Nilsen (PhD) from Heidi Lyng's Clinical Radiation Biology group at the Departement of Radiation Biology at the Institute for Cancer Research writes about cancer treatment and how the use of RNA as biomarkers may be useful in order to give more precise radiation doses as well as to improve the targeting of chemotherapy.
In a recent paper in Nature (journal impact factor 42), project leader Camilla Raiborg and her co-workers in Harald Stenmark´s group at Institute for Cancer Research and Centre for Cancer Biomedicine show an unexpected connection between endosomes (organelles involved in protein import into cells) and the endoplasmic reticulum (ER, organelle involved in protein export) in formation of cellular protrusions.
EMBO journal has already published a commentary article about the findings, entitled "A grab to move on: ER–endosome contacts in membrane protrusion formation and neurite outgrowth".
The well visited Norwegian popular science website forskning.no has also published an article about the findings, entitled "The secrets of neurone protrusion formation revealed".
Improved methods for the treatment of metabolic diseases affecting children's nervous system
May 20, 2015
Selected latest publications
Journ. Impact factor > 8 First or last author from Oslo University Hospital
Genetics of liver disease: From pathophysiology to clinical practice
J Hepatol, 62 (1S), S6-S14
Emerging treatments for post-transplantation diabetes mellitus
Nat Rev Nephrol (in press)
More selected publications